Trial Profile
To compare levels of persistence and adherence to Mirabegron than antimuscarinics in patients with overactive bladder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jun 2017
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary) ; Fesoterodine; Imidafenacin; Oxybutynin; Propiverine; Solifenacin; Tolterodine
- Indications Overactive bladder
- Focus Therapeutic Use
- 08 Jun 2017 New trial record
- 16 May 2017 Results presented at the 112th Annual Meeting of the American Urological Association.